DTM Highlights

In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) gives an overview of RocketAP and discusses how the RocketAP compares to the USS-Virginia system and also what the next steps in the clinical development of the Rocket AP will be. The abstract entitled: ‘RocketAP in Practice: Results from Pilot and Feasibility […]

An artificial pancreas is a system made of three parts that work together to mimic how a healthy pancreas controls blood glucose in the body. In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) discusses the major challenges in the development of artificial pancreas systems. The abstract entitled: ‘RocketAP in Practice: Results from Pilot […]

In this touchENDOCRINOLOGY interview, Prof. Carol Levy (Icahn School of Medicine at Mount Sinai, New York City, NY, USA) discusses her study which evaluated adults with type 2 diabetes using the t:slim X2 insulin pump with Control-IQ technology to show that Control-IQ technology could offer considerable benefit to individuals with type 2 diabetes. The abstract […]

Insulin pumps are electronic devices that help you stabilise your blood glucose levels and control your diabetes. Control-IQ technology could be a powerful management solution for therapy needs of individuals living with type 2 diabetes. In this touchENDOCRINOLOGY interview, Prof. Carol Levy (Icahn School of Medicine at Mount Sinai, New York City, NY, USA) discusses the benefits […]

Self-monitoring of blood glucose (SMBG) is a well established and a highly valuable approach for the daily management of type 2 diabetes. In addition, it has been demonstrated to be a beneficial approach for the achievement of long-term glycemic management in patients with type 2 diabetes. In this touchENDOCRINOLOGY interview, Dr Michelle Magee (MedStar Washington Hospital […]

ONWARDS 4 compared once-weekly insulin icodec with once-daily insulin glargine, both in combination with mealtime insulin. The objective of the trial was to assess the efficacy and safety of insulin icodec in people with type 2 diabetes treated with basal and bolus insulin. In this touchENDOCRINOLOGY interview, Prof. Chantal Mathieu (University Hospital Gasthuisberg Leuven, Leuven, […]

Insulin icodec offers a reduction in dosing frequency of injectable therapies to once weekly, which may improve convenience, adherence, and quality of life over once-daily basal insulin analogs. In this touchENDOCRINOLOGY interview, Prof. Chantal Mathieu (University Hospital Gasthuisberg Leuven, Leuven, Belgium) discusses the limitations of once daily basal insulin analogues and gives an overview on insulin […]

 In this touchENDOCRINOLOGY interview, Dr Christian Hansen (Steno Diabetes Center Copenhagen, Birkerød, Denmark) discusses the unmet needs that remain in the diagnosis and treatment of cardiac autonomic neuropathy. The abstract entitled: ‘Cardiac Autonomic Neuropathy Sensors for Diabetes‘ was presented at the 22nd Annual Diabetes Technology Meeting, 03-05 Nov, 2022. Questions: What unmet needs remain and what advances […]

Cardiac autonomic neuropathy (CAN) is a serious complication of diabetes. In this touchENDOCRINOLOGY interview, Dr Christian Hansen (Steno Diabetes Center Copenhagen, Birkerød, Denmark) discusses the clinical manifestations of CAN, its diagnosis and what medical devices are available for the detection of CAN. The abstract entitled: ‘Cardiac Autonomic Neuropathy Sensors for Diabetes‘ was presented at the 22nd […]